Skip to content

APHUT-Rex 2x Long Aph Daily Target ETF

Take a betNewRanked #732 of 775 in this goal

Seeks daily investment results of 200% of the daily performance of APH.

By Rex · Launched 2026

Annual Cost

1.50%

#5,447 of 5,562 · expensive

Fund Size

$4M

#5,180 of 5,562 · small

Return (1Y)Goal

N/A

Track Record

4 months

#5,254 of 5,562 · young

Performance

Total-return NAV · USD
Growth of $10,000
$10,070+0.7%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Strategy

Leveraged

What it actually holds

By weight

Concentration

Top 1 holdings = 9.9% of fundwell diversified

First American Government Obligs XFGXXX
9.9%

Asset allocation

Stocks
198.8%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-43.5%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange
Cboe BZX, NYSE American

Full fund details

Objective
Seeks daily investment results of 200% of the daily performance of APH.
Strategy
Invests primarily in financial instruments to provide 200% daily exposure to APH. May use call options or direct stock investments, but swaps are preferred for efficient leverage.
Inception date
February 17, 2026
Fund family
Rex

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged single stock
Critical

Leveraged single-stock ETF — documented structural drag

Single-stock leveraged ETFs magnify one stock's daily move. Research on these products (Bessembinder et al., 2024) finds 56% posted negative absolute returns over one year, with ~9.5% annual drag versus the underlying stock. Daily rebalancing plus financing costs work against the investor on any holding period longer than a few days.

Source: Bessembinder, Cooper, Zhang — 'Leveraged Single-Stock ETFs' (SSRN 2024)

Why we flagged this: strategy=leveraged + single_stock_wrapper

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've reviewed APHU. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19